Steps to block key enzyme action in heart failure mappedNovember 12th, 2008 - 1:47 pm ICT by ANI
Washington, Nov 12 (ANI): In a breakthrough study, scientists at Johns Hopkins have mapped out a key chemical step involved in blocking enzyme action in heart failure.
The team showed how the enzyme, phosphodiesterase 5, or PDE5A, involved in heart failure, slows down the breakdown of another vital compound called, cyclic guanosine monophosphate (cyclic GMP), which is critical to cell growth and muscle contraction.
They identified a sulfur- and nitrogen-containing molecule, or S-nitrosyl group that chemically alters the enzyme’’s amino-acid building blocks.
This so-called S-nitrosylation of amino acid cysteine 181 lead to a 25 percent reduction in PDE5A activity, pinpointing how the enzyme’’s action is suppressed.
“Knowing the molecular make-up and activity of a protein is critical to understanding heart failure because these problem-specific biochemical reactions are magnified in the disease,” said senior study investigator Jennifer Van Eyk, Ph.D., a professor at the Johns Hopkins University School of Medicine and its Heart and Vascular Institute.
“Targeted drug therapies can now be developed and tested to work specifically on cysteine 181, to block the PDE5A enzyme, lower the breakdown of cyclic GMP, and potentially stall progression of heart failure and hypertrophy,” she added.
The researchers said that their next step is to investigate how PDE5A affects where cyclic GMP is broken down or made, with the goal of determining if the enzyme also controls the known cell pooling of the compound.
The study was presented at the American Heart Association’’s annual Scientific Sessions in New Orleans. (ANI)
- Viagra relatives could minimize abnormally large hearts - Sep 25, 2009
- Viagra compounds found to shrink abnormally large hearts - Sep 25, 2009
- Out-of-tune protein precipitates heart failure - Sep 13, 2012
- Measuring oxidative stress may help predict atrial fibrillation risk - Apr 05, 2011
- How omega-3 fatty acids keep blindness at bay - Feb 10, 2011
- Nutraceuticals in energy drinks, foods - Mar 20, 2011
- Scientists find new ways of choking tumours - Aug 24, 2012
- Ancient bacteria could pave way for new and improved sunscreens - Sep 03, 2010
- Gene discovery could lead to healthier food, better biofuel production - Nov 23, 2010
- New soybean meal sources 'are good fish meal alternatives' - Feb 08, 2011
- Brain chemical influences our judgements - Apr 15, 2011
- Scientists get glimpse of how 'code' of life may have emerged - Mar 24, 2011
- Volcanoes, lightning may have sparked life on earth - Mar 22, 2011
- Viagra can prevent heart from high blood pressure damage - Jan 06, 2009
- Now get a tan without exposure to cancerous UV rays - Oct 15, 2010
Tags: american heart association, biochemical reactions, breakthrough study, building blocks, drug therapies, enzyme action, gmp, guanosine monophosphate, heart failure, hypertrophy, johns hopkins university, johns hopkins university school, johns hopkins university school of medicine, molecule, muscle contraction, nitrogen, school of medicine, understanding heart, van eyk, vascular institute